Teva Pharmaceutical Industries Ltd. (TEVA)

Sector:Health Care
Super Investor Stats:
Ownership count:5
Ownership rank:91
% of all portfolios:0.053%
Hold Price * :$16.25
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q2  2024
≡ Lee Ainslie - Maverick Capital Add 13.79% 7,938 0.00
≡ Bill Miller - Miller Value Partners Reduce 5.60% 650 0.01
≡ Harry Burn - Sound Shore Reduce 9.78% 733,244 0.40
Q1  2024
≡ David Einhorn - Greenlight Capital Add 21.00% 56,380 0.04
≡ Lee Ainslie - Maverick Capital Reduce 8.73% 5,502 0.00
≡ Bill Miller - Miller Value Partners Reduce 13.43% 1,800 0.02
≡ Harry Burn - Sound Shore Reduce 15.97% 1,424,544 0.63
≡ David Abrams - Abrams Capital Management Sell 100.00% 5,996,836 1.95
Q4  2023
≡ Lee Ainslie - Maverick Capital Add 90.45% 29,942 0.00
≡ Harry Burn - Sound Shore Add 12.61% 998,522 0.36
≡ David Einhorn - Greenlight Capital Buy 268,470 0.14
≡ Bill Miller - Miller Value Partners Reduce 5.80% 825 0.01
≡ Samantha McLemore - Patient Capital Management Reduce 20.00% 25,000 0.02
≡ David Abrams - Abrams Capital Management Reduce 24.72% 1,969,597 0.64
Q3  2023
≡ Harry Burn - Sound Shore Buy 7,920,712 3.09
≡ Lee Ainslie - Maverick Capital Reduce 34.56% 17,483 0.01
≡ Samantha McLemore - Patient Capital Management Reduce 59.16% 181,054 0.12
≡ Bill Miller - Miller Value Partners Reduce 82.68% 67,912 0.43
Q2  2023
≡ Lee Ainslie - Maverick Capital Reduce 4.31% 2,277 0.00
≡ Samantha McLemore - Patient Capital Management Reduce 51.11% 319,946 0.14
≡ Bill Miller - Miller Value Partners Reduce 97.91% 3,847,647 19.67
Q1  2023
≡ Lee Ainslie - Maverick Capital Add 68.10% 21,416 0.00
≡ Bill Miller - Miller Value Partners Reduce 23.65% 1,217,243 0.67
≡ Samantha McLemore - Patient Capital Management Reduce 24.81% 206,575 0.82
≡ David Abrams - Abrams Capital Management Reduce 50.00% 7,966,432 2.23
Q4  2022
≡ Lee Ainslie - Maverick Capital Buy 31,449 0.01
≡ Samantha McLemore - Patient Capital Management Reduce 29.14% 342,425 1.54
≡ David Abrams - Abrams Capital Management Reduce 33.33% 7,966,431 2.59
≡ Bill Miller - Miller Value Partners Reduce 44.39% 4,107,848 2.42
Q3  2022
≡ David Abrams - Abrams Capital Management Reduce 0.61% 147,060 0.03
≡ Bill Miller - Miller Value Partners Reduce 0.85% 79,715 0.04
≡ Samantha McLemore - Patient Capital Management Reduce 1.50% 17,950 0.07
Q2  2022
≡ Samantha McLemore - Patient Capital Management Add 19.19% 192,100 0.71
≡ Bill Miller - Miller Value Partners Reduce 7.20% 724,149 0.30
Q1  2022
≡ Samantha McLemore - Patient Capital Management Add 33.46% 250,950 0.93
≡ Bill Miller - Miller Value Partners Add 4.13% 399,220 0.14
Q4  2021
≡ Bill Miller - Miller Value Partners Reduce 0.91% 88,610 0.03
≡ Warren Buffett - Berkshire Hathaway Sell 100.00% 42,789,295 0.14
Q3  2021
≡ Bill Miller - Miller Value Partners Reduce 10.86% 1,187,654 0.39
≡ Lee Ainslie - Maverick Capital Sell 100.00% 44,879 0.00
Q2  2021
≡ Bill Miller - Miller Value Partners Add 3.62% 381,718 0.10
≡ Lee Ainslie - Maverick Capital Reduce 71.20% 110,962 0.00
≡ Meridian Contrarian Fund Sell 100.00% 1,079,000 1.82
Q1  2021
≡ Lee Ainslie - Maverick Capital Add 248.84% 111,167 0.01
≡ Bill Miller - Miller Value Partners Add 47.82% 3,414,365 1.12
≡ Meridian Contrarian Fund Add 30.00% 249,000 0.42
Q4  2020
≡ Meridian Contrarian Fund Add 53.99% 291,000 0.47
≡ Bill Miller - Miller Value Partners Reduce 11.79% 953,998 0.31
≡ Lee Ainslie - Maverick Capital Reduce 64.31% 80,503 0.02
Q3  2020
≡ Bill Miller - Miller Value Partners Add 3.10% 243,226 0.09
≡ Lee Ainslie - Maverick Capital Buy 125,177 0.02
≡ Meridian Contrarian Fund Reduce 21.43% 147,000 0.27
Q2  2020
≡ Meridian Contrarian Fund Buy 686,000 1.83
≡ Bill Miller - Miller Value Partners Reduce 0.86% 67,890 0.04
Q1  2020
≡ Warren Buffett - Berkshire Hathaway Reduce 1.06% 460,000 0.00
≡ Bill Miller - Miller Value Partners Reduce 19.48% 1,915,705 1.11
≡ Lee Ainslie - Maverick Capital Sell 100.00% 461,715 0.07
Q4  2019
≡ Bill Miller - Miller Value Partners Add 15.82% 1,342,915 0.47
≡ Lee Ainslie - Maverick Capital Reduce 30.17% 199,500 0.03
≡ Francis Chou - Chou Associates Sell 100.00% 15,000 0.06
Q3  2019
≡ David Abrams - Abrams Capital Management Add 33.25% 6,000,000 1.16
≡ Bill Miller - Miller Value Partners Add 30.63% 1,990,900 0.56
≡ Lee Ainslie - Maverick Capital Buy 661,215 0.07
Q2  2019
≡ Bill Miller - Miller Value Partners Add 43.10% 1,957,720 0.72
≡ Lee Ainslie - Maverick Capital Sell 100.00% 94,530 0.02
Q1  2019
≡ Bill Miller - Miller Value Partners Add 16.12% 630,730 0.39
≡ David Abrams - Abrams Capital Management Reduce 2.57% 476,016 0.21
≡ Lee Ainslie - Maverick Capital Reduce 60.81% 146,690 0.03
Q4  2018
≡ Bill Miller - Miller Value Partners Add 0.16% 6,350 0.00
≡ Lee Ainslie - Maverick Capital Buy 241,220 0.05
≡ David Abrams - Abrams Capital Management Reduce 5.12% 1,000,000 0.64
Q3  2018
≡ Bill Miller - Miller Value Partners Add 50.87% 1,316,840 0.94
≡ David Abrams - Abrams Capital Management Reduce 1.12% 220,751 0.13
Q2  2018
≡ Bill Miller - Miller Value Partners Add 17.93% 393,640 0.37
≡ Warren Buffett - Berkshire Hathaway Add 6.68% 2,709,585 0.03
Q1  2018
≡ Bill Miller - Miller Value Partners Add 325.29% 1,678,860 1.25
≡ Warren Buffett - Berkshire Hathaway Add 114.77% 21,663,989 0.20
Q4  2017
≡ Bill Miller - Miller Value Partners Buy 516,112 0.43
≡ Warren Buffett - Berkshire Hathaway Buy 18,875,721 0.19
≡ David Abrams - Abrams Capital Management Reduce 8.70% 1,880,763 1.20
≡ Francis Chou - Chou Associates Reduce 97.03% 490,000 3.92
Q3  2017
≡ David Abrams - Abrams Capital Management Buy 21,623,886 14.85
Q2  2017
≡ Francis Chou - Chou Associates Add 134.88% 290,000 3.03
≡ David Tepper - Appaloosa Management Sell 100.00% 2,175,000 1.22
Q1  2017
≡ Francis Chou - Chou Associates Buy 215,000 2.33
≡ David Tepper - Appaloosa Management Reduce 56.96% 2,878,000 1.61
≡ David Katz - Matrix Asset Advisors Sell 100.00% 37,500 2.30
Q4  2016
≡ David Katz - Matrix Asset Advisors Add 2.74% 1,000 0.06
≡ David Tepper - Appaloosa Management Buy 5,053,000 3.42
Q3  2016
≡ David Katz - Matrix Asset Advisors Add 8.96% 3,000 0.24
Q1  2016
≡ David Katz - Matrix Asset Advisors Reduce 14.10% 5,500 0.52
Q2  2015
≡ David Katz - Matrix Asset Advisors Reduce 4.18% 1,700 0.14
Q1  2015
≡ David Katz - Matrix Asset Advisors Add 1.75% 700 0.06
Q4  2014
≡ Thomas Gayner - Markel Group Sell 100.00% 444,000 0.67
Q3  2014
≡ Thomas Gayner - Markel Group Reduce 36.02% 250,000 0.38
Q2  2014
≡ David Katz - Matrix Asset Advisors Reduce 3.61% 1,500 0.10
Q1  2014
≡ Thomas Gayner - Markel Group Reduce 0.84% 5,900 0.01
≡ David Katz - Matrix Asset Advisors Reduce 23.15% 12,500 0.80
Q4  2013
≡ Thomas Gayner - Markel Group Reduce 0.01% 100 0.00
Q3  2013
≡ David Katz - Matrix Asset Advisors Add 20.00% 9,000 0.48

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.